MATAS Matas A/S
Matas A/S operates a chain of retail stores that offer beauty, personal care, health and wellbeing, and household products in Denmark, Sweden, Norway, and internationally. Its products include cosmetics, fragrances, and skin and hair care products. The company also offers medicine and nursing products; vitamins, minerals, health supplements, specialty foods, and herbal medicinal products, as well as sports, nutrition, and exercise; mother and child care; sexual wellness; and oral, foot, intimate care, hair removal, and special skincare products. In addition, it provides house and garden products, including cleaning and maintenance, electrical products, interior decoration, and textiles; and clothing and accessories, such as footwear, hair ornaments, jewelry, and toilet bags. It operates through physical stores, wholesale, and websites, such as matas.dk. Matas A/S was founded in 1949 and is based in Allerød, Denmark.…
Industry Peers
Specialty RetailKey Statistics
About Matas (CPH: MATAS)
›
Matas (CPH: MATAS) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Specialty Retail industry, part of the Consumer Cyclical sector, and reports about 3,397 employees.
The shares were at 78.10 DKK on 19 November 2026, down 39.7% over 52 weeks. Its 52-week range is 78.10 DKK to 131.80 DKK, and it trades at the bottom of that range.
At a market capitalisation of 2.87B DKK, it trades at 16.5 times trailing earnings and 6.3 times forward earnings. The median trailing P/E of its 20 largest Specialty Retail peers is 16.6, so MATAS is valued in line with them. It pays a dividend yielding 2.51% (it pays out 42% of its earnings), against a median of 2.50% among the dividend payers in that peer group.
Matas reports return on equity of 6.5%, an operating margin of 5.8% and revenue up 2.4% year over year.
Its debt exceeds its cash by 4.18B DKK, a debt-to-equity ratio of 1.09. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 121.67 DKK is 55.8% above the current price. The next earnings report is expected on 3 February 2027.